Karas Eric Insider Trades

Insider Trading History

Track insider trading activity for Karas Eric. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Commercial Officer
Holding Value $3.95M 519,588 shares
Last Trade
Jun 12, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$244k 25,000 shares
$9.76
$7.61
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Commercial Officer
Holding Value $92.7k 12,176 shares
Last Trade
Jun 12, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$250k 25,000 shares
$10.00
$7.61
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Commercial Officer
Holding Value $283k 37,176 shares
Last Trade
Jun 12, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$244k 25,000 shares
$9.76
$7.61
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Commercial Officer
Holding Value $1.83M 240,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.76M 240,000 shares
$11.49
$7.61
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Commercial Officer
Holding Value $78.5k 10,315 shares
Last Trade
Jul 01, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$255k 15,000 shares
$16.99
$7.61
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Commercial Officer
Holding Value $4.14M 544,588 shares
Last Trade
Jul 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$241k 15,000 shares
$16.09
$7.61
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Commercial Officer
Holding Value $193k 25,315 shares
Last Trade
Jul 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$241k 15,000 shares
$16.09
$7.61
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Commercial Officer
Holding Value $4.26M 559,588 shares
Last Trade
Jun 18, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$239k 15,000 shares
$15.91
$7.61
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Commercial Officer
Holding Value $58.6k 7,696 shares
Last Trade
Jun 18, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$240k 15,000 shares
$16.00
$7.61
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Commercial Officer
Holding Value $173k 22,696 shares
Last Trade
Jun 18, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$239k 15,000 shares
$15.91
$7.61
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Commercial Officer
Holding Value $135k 17,696 shares
Last Trade
Mar 20, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$143k 10,000 shares
$14.31
$7.61
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Commercial Officer
Holding Value $58.6k 7,696 shares
Last Trade
Mar 20, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$140k 10,000 shares
$14.00
$7.61
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Commercial Officer
Holding Value $4.37M 574,588 shares
Last Trade
Mar 20, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$143k 10,000 shares
$14.31
$7.61
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Commercial Officer
Holding Value $1.16M 152,300 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.63M 152,300 shares
$10.71
$7.61
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Commercial Officer
Holding Value $91.1k 11,976 shares
Last Trade
Dec 04, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$90.6k 6,283 shares
$14.42
$7.61
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Commercial Officer
Holding Value $4.45M 584,588 shares
Last Trade
Dec 04, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$90.6k 6,283 shares
$14.42
$7.61
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Commercial Officer
Holding Value $43.3k 5,693 shares
Last Trade
Dec 04, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$88k 6,283 shares
$14.00
$7.61
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Commercial Officer
Holding Value $71.6k 9,410 shares
Last Trade
Dec 02, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$49.5k 3,717 shares
$13.32
$7.61
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Commercial Officer
Holding Value $43.3k 5,693 shares
Last Trade
Dec 02, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$52.4k 3,717 shares
$14.11
$7.61
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Chief Commercial Officer
Holding Value $4.5M 590,871 shares
Last Trade
Dec 02, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$49.5k 3,717 shares
$13.32
$7.61

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up